novo nordisk zepbound news - Search News

Eli Lilly Whomps Novo Nordisk

Wall Street Journal on MSN · 2d

Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study

People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.

Business Today on MSN · 19h

Eli Lilly's Zepbound takes on Novo Nordisk's Wegovy in obesity drug showdown

In the fierce race to dominate the weight loss drug market, global pharmaceutical giant Eli Lilly announced on Wednesday that its weight loss treatment, Zepbound (tirzepatide), outperformed Novo Nordisk’s Wegovy (semaglutide) in a recent clinical trial.

Investopedia on MSN · 2d

Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial

Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.

17h

Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup

Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing ...

Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming Novo, and more

Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results